Delivery Order SPE2DB22D2007-SPE2DB24FJ0ND
- Not listed
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XYLOCAINE-MPF 1% VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price delivery order contract has a potential value of $1,042.89 and a period of performance through February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not associated with any set-aside designation. The company has a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,536.32. The order is for the supply of XYLOCAINE-MPF 2% VIAL 2ML, a local anesthetic medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 26, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,136.02, is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, with a ceiling value of $2,008.60 and a period of performance through June 11, 2025. The contract is designated as a Firm Fixed Price contract and is not set aside for any specific business category. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Xylocaine-MPF 1% vial 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,173.76 and is a Firm Fixed Price Delivery Order with a completion date of May 24, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic pharmaceutical product, with a ceiling value of $2,233.50. This firm fixed price delivery order, awarded on December 16, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of December 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, identified as SPE2DX15D7057|SPE2DX24FLCEW, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, which is not set aside, is for the delivery of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award has a ceiling value of $1,487.42 and a completion date of August 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
- This federal contract award, with a ceiling value of $2,054.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4559068759 - XYLOCAINE-MPF 2% AMPUL 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.13 firm fixed-price delivery order is for the supply of 4566747173 ! XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0NDDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the delivery of XYLOCAINE 2% VIAL 20ML, a pharmaceutical product, with a ceiling value of $1,637.26 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense through DLA Troop Support Medical. This award is not associated with any set-aside designation. In addition to this delivery order, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/13/24 |